pLX304 Luciferase-V5 blast Citations (5)
Originally described in: Tumor-Suppressor Inactivation of GDF11 Occurs by Precursor Sequestration in Triple-Negative Breast Cancer.Bajikar SS, Wang CC, Borten MA, Pereira EJ, Atkins KA, Janes KA Dev Cell. 2017 Nov 20;43(4):418-435.e13. doi: 10.1016/j.devcel.2017.10.027. PubMed Journal
Articles Citing pLX304 Luciferase-V5 blast
| Articles |
|---|
| Tousled-like kinase 2 targets ASF1 histone chaperones through client mimicry. Simon B, Lou HJ, Huet-Calderwood C, Shi G, Boggon TJ, Turk BE, Calderwood DA. Nat Commun. 2022 Feb 8;13(1):749. doi: 10.1038/s41467-022-28427-0. PubMed |
| A bi-steric mTORC1-selective inhibitor overcomes drug resistance in breast cancer. Meng D, Zhao X, Yang YC, Navickas A, Helland C, Goodarzi H, Singh M, Bandyopadhyay S. Oncogene. 2023 Jul;42(28):2207-2217. doi: 10.1038/s41388-023-02737-z. Epub 2023 Jun 1. PubMed |
| Role of Nudt2 in Anchorage-Independent Growth and Cell Migration of Human Melanoma. Hidmi S, Nechushtan H, Razin E, Tshori S. Int J Mol Sci. 2023 Jun 22;24(13):10513. doi: 10.3390/ijms241310513. PubMed |
TEAD Inhibition Overcomes YAP1/TAZ-driven Primary and Acquired Resistance to KRASG12C Inhibitors.
Edwards AC, Stalnecker CA, Jean Morales A, Taylor KE, Klomp JE, Klomp JA, Waters AM, Sudhakar N, Hallin J, Tang TT, Olson P, Post L, Christensen JG, Cox AD, Der CJ.
Cancer Res. 2023 Nov 7. doi: 10.1158/0008-5472.CAN-23-2994.
PubMed
Associated Plasmids |
| Fibroblast Stromal Support Model for Predicting Human Papillomavirus-Associated Cancer Drug Responses. James CD, Lewis RL, Fakunmoju AL, Witt A, Youssef AH, Wang X, Rais NM, Tadimari Prabhakar A, Machado JM, Otoa R, Bristol ML. bioRxiv [Preprint]. 2024 Aug 1:2024.04.09.588680. doi: 10.1101/2024.04.09.588680. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.